The DOI matches its Crossref record.
Health care expenditures for people with diabetes mellitus, 1992.
Abstract
The purpose of this report is to estimate diabetes prevalence and annual health care costs for people with diabetes in 1992, compare average annual costs for diabetics and nondiabetics, and estimate the portion of total U.S. health care expenditures incurred by people with the disease. Data from the 1987 National Medical Expenditure Survey were used to estimate diabetes prevalence and health care expenditures for diabetics in 1992. Diabetics were identified based on self-reports of a physician diagnosis of diabetes, a history of taking diabetic medications, or an encounter with the health care system specifically related to diabetes. Identified diabetics were classified as confirmed if they had a history of taking diabetic medications, had a diabetes-specific encounter with the health care system, or purchased diabetic equipment. Estimates of diabetes prevalence and health care expenditures were calculated separately for identified and confirmed diabetics using the National Medical Expenditure Survey database. Total health care expenditures included costs associated with inpatient hospital care, outpatient hospital care, office visits to a physician or other provider, emergency room visits, home health care, prescription drugs, dental care, and durable medical equipment purchases. We estimate that percapita annual health care expenditures in 1992 were more than three times greater for diabetics ($9,493) than for nondiabetics ($2,604). Percapita expenditures for confirmed diabetics ($11,157) were more than four times greater than for nondiabetics. In 1992, diabetics constituted 4.5% of the U.S. population but accounted for 14.6% of total U.S. health care expenditures ($105 billion). Confirmed diabetics constituted 3.1% of the U.S. population but accounted for 11.9% of total U.S. health care expenditures ($85 billion). This study found that health care expenditures for people with diabetes constituted about one in seven health care dollars spent in 1992. Health care reform and insurers should take note of these findings and structure benefit packages to promote care likely to reduce the costs of caring for diabetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus
Schauer, P. R., Burguera, B., Ikramuddin, S., Cottam, D., Gourash, W., Hamad, G., Eid, G. M., Mattar, S., Ramanathan, R., Barinas-Mitchel, E., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000089851.41115.1b · Cited by 1,183
Pharmacologic Therapy for Type 2 Diabetes Mellitus
DeFronzo, R. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00008 · Cited by 1,173
Palmer, A. J., Roze, S., Valentine, W. J., Minshall, M. E., Foos, V., Lurati, F. M., Lammert, M., & Spinas, G. A. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x1980 · Cited by 526
Miller, D. R., Safford, M. M., & Pogach, L. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.suppl_2.b10 · Cited by 425
Empowerment: from philosophy to practice
Feste, C., & Anderson, R. M. (1995) · Patient Education and Counseling · doi:10.1016/0738-3991(95)00730-n · Cited by 394
Revealing the cost of Type II diabetes in Europe
Jönsson, B. (2002) · Diabetologia · doi:10.1007/s00125-002-0858-x · Cited by 392
Eriksson, J., Lindström, J., Valle, T., Aunola, S., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Lauhkonen, M., Lehto, P., et al. (1999) · Diabetologia · doi:10.1007/s001250051229 · Cited by 368
Skyler, J. S., & Oddo, C. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.289 · Cited by 359
Feld, S. (2002) · Endocrine Practice · doi:10.4158/ep.8.s1.40 · Cited by 359
Vagelatos, N. T., & Eslick, G. D. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs012 · Cited by 320
Ali, M. K., Weber, M. B., & Narayan, K. M. V. (2010) · Textbook of Diabetes · doi:10.1002/9781444324808.ch5 · Cited by 315
Holmes‐Walker, D. J., Llewellyn, A. C., & Farrell, K. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02152.x · Cited by 296
Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes
Levine, B.-S., Anderson, B. J., Butler, D. A., Antisdel, J. E., Brackett, J., & Laffel, L. M. B. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116283 · Cited by 279
The Direct Medical Cost of Type 2 Diabetes
Brandle, M., Zhou, H., Smith, B. R. K., Marriott, D., Burke, R., Tabaei, B. P., Brown, M. B., & Herman, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2300 · Cited by 269
Scott, C. R., Smith, J. M., Cradock, M. M., & Pihoker, C. (1997) · PEDIATRICS · doi:10.1542/peds.100.1.84 · Cited by 265
Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2518 · Cited by 262
Clarke, P. M., Glasziou, P., Patel, A., Chalmers, J., Woodward, M., Harrap, S. B., Salomon, J. A., & on behalf of the ADVANCE Collaborative Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000236 · Cited by 159
Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.
Chiu, K. C., Cohan, P., Lee, N. P., & Chuang, L. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1353 · Cited by 154
The Pathogenesis of Type II Diabetes Mellitus:A Polygenic Disease
Sacks, D. B., & McDonald, J. M. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.2.149 · Cited by 93
Metadata
- Authors
- Rubin, R. J., Altman, W. M., & Mendelson, D. N.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-04
- Volume
- 78
- Issue
- 4
- Pages
- 809A-809F
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041154843
- Cited by
- 378
- References
- 0
- FWCI
- 71.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.